Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
48
WINT Quote, Financials, Valuation and Earnings
Last price:
$1.02
Seasonality move
:
-6.37%
Day range:
$0.65 - $1.06
52-week range:
$0.36 - $737.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.42x
P/B ratio:
0.32x
Volume:
49.2M
Avg. volume:
15.4M
1-year change:
-99.51%
Market cap:
$3.3M
Revenue:
--
EPS (TTM):
-$1,261.36
Earnings Data
Next earnings date for WINT
Aug 19
2025
Most recent earnings per share
-$4.63
Missed by $4.63
(May 16/2025)
Consensus Estimate
--
(May 16/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
WINT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/16/2025 | Q1 | -- | -- | -$4.63 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | $0.27 | -$39.00 | $39.27 |
| 11/27/2024 | Q3 | -- | -- | -$211.50 | -$113.50 | -$98.00 |
| 08/19/2024 | Q2 | -- | -- | -$1,045.50 | -$405.50 | -$640.00 |
| 05/15/2024 | Q1 | -- | -- | $1,099.37 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$773.64 | -$846.00 | $72.36 |
| 11/09/2023 | Q3 | -- | -- | -$773.50 | -$567.00 | -$206.50 |
| 06/30/2023 | Q2 | -- | -- | -$1,473.50 | -$612.00 | -$861.50 |
| 03/31/2023 | Q1 | -- | -- | -$77,085.00 | -$504.00 | -$76,581.00 |
| 12/31/2022 | Q4 | -- | -- | -$11,709.00 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$5,594.48 | -- | -- |
| 08/05/2022 | Q2 | -- | -- | -$26,543.64 | -- | -- |
| 05/13/2022 | Q1 | -- | -- | -$12,859.18 | -- | -- |
| 03/29/2022 | Q4 | -- | -- | -$20,816.88 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$13,849.92 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$63,050.59 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$15,370.50 | -- | -- |
| 03/15/2021 | Q4 | -- | -- | -$19,824.47 | -- | -- |
| 11/16/2020 | Q3 | -- | -- | -$23,989.36 | -- | -- |
| 08/13/2020 | Q2 | -- | -- | -$25,556.15 | -- | -- |
| 05/13/2020 | Q1 | -- | -- | -$21,493.42 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$24,259.87 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$29,941.18 | -- | -- |
| 06/30/2019 | Q2 | -- | $158K | -$27,046.22 | -- | -- |
| 03/31/2019 | Q1 | -- | $40K | -$27,466.39 | -- | -- |
| 12/31/2018 | Q4 | -- | $304K | -$97,752.10 | -- | -- |
| 09/30/2018 | Q3 | -- | $229K | -$145,444.44 | -- | -- |
| 06/30/2018 | Q2 | -- | $1.1M | -$113,037.04 | -- | -- |
| 03/31/2018 | Q1 | -- | $204K | -$196,173.91 | -- | -- |
| 12/31/2017 | Q4 | -- | $102K | $107,521.74 | -- | -- |
| 11/14/2017 | Q3 | -- | $17K | -$1,535,400.00 | -- | -- |
| 08/21/2017 | Q2 | -- | $1.1M | -$2,428,000.00 | -- | -- |
| 03/31/2017 | Q1 | -- | $219K | -$4,109,333.33 | -- | -- |
| 03/31/2017 | Q4 | -- | $900K | -$2,200,666.67 | -- | -- |
| 09/30/2016 | Q3 | -- | $961K | -$2,787,666.67 | -- | -- |
| 08/10/2016 | Q2 | -- | $106K | -$3,541,333.33 | -- | -- |
| 05/12/2016 | Q1 | -- | $75K | -$4,633,666.67 | -- | -- |
| 03/16/2016 | Q4 | -- | $655K | -$3,653,333.33 | -- | -- |
| 11/12/2015 | Q3 | -- | $66K | -$10,778,000.00 | -- | -- |
Windtree Therapeutics Earnings Questions
-
How Much did Windtree Therapeutics Generate in Revenue Last Quarter?
Windtree Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Windtree Therapeutics Beat Earnings Last Quarter?
Windtree Therapeutics announced earnings per share of -$4.63 which represents a miss of analyst forecast a -- per share.
-
Is Windtree Therapeutics Profitable?
Windtree Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Windtree Therapeutics EPS Next Year?
Windtree Therapeutics's earnings are forecast to decrease from -$5,217.50 per share to -$173.00 per share next year representing a decrease of -90.68%.
-
When is Windtree Therapeutics's Earnings Date?
Windtree Therapeutics's next earnings date is August 19, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
